What is BIAF stock price today?

BIAF (Bioaffinity Technologies Inc) stock is trading at $1.31 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is BIAF stock going up or down today?

BIAF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy BIAF stock now?

The decision to buy BIAF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is BIAF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for BIAF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is BIAF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if BIAF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is BIAF's P/E ratio?

P/E ratio data for BIAF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is BIAF's market cap?

BIAF (Bioaffinity Technologies Inc) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is BIAF's price to book ratio?

BIAF trades at a price-to-book (P/B) ratio of 0.69, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does BIAF pay dividends?

BIAF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is BIAF's dividend yield?

BIAF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is BIAF stock a good long-term investment?

BIAF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is BIAF's revenue growth rate?

BIAF has shown revenue growth of -0.4% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

BIAF is currently operating at a loss. Some companies prioritize growth over profitability in early stages. Review our financial analysis for detailed insights.

What are the risks of investing in BIAF?

Key risks for BIAF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does BIAF compare to its competitors?

Compare BIAF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize BIAF's performance and positioning.

What is BIAF's stock price target for 2026?

Our AI model provides price targets for BIAF based on fundamental analysis: Bull case $1.70 (+30%), Base case $1.51 (+15%), Bear case $1.18 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about BIAF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for BIAF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is BIAF's next earnings report?

BIAF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

BIAF - Bioaffinity Technologies Inc

NYSE * Health Care * Life Sciences Tools & Services

$1.31

$-0.06 (-4.38%)

About Bioaffinity Technologies Inc

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.

BIAF Key Statistics

Market Cap

$6.16M

P/B Ratio

0.69

EPS

$-13.83

Revenue Growth

-0.4%

Profit Margin

-2.2%

Employees

How BIAF Compares to Peers

BIAF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
BIAF(This stock)	$6.16M	N/A	-0%	-2.2%	-
AAPLApple Inc	$3.66T	33.8	6%	0.3%	vs AAPL
MSFTMicrosoft Corp	$3.38T	36.3	15%	0.4%	vs MSFT
GOOGLAlphabet Inc	$3.89T	32.6	0%	0.3%	vs GOOGL
AMZNAmazon Com	$2.56T	33.8	0%	0.1%	vs AMZN
NVDANvidia Corp	$4.33T	47.9	114%	0.5%	vs NVDA

Bioaffinity Technologies Inc Company Information

Headquarters: Texas; U.S.A
Website: www.bioaffinitytech.com
Sector: Health Care
Industry: Life Sciences Tools & Services

About Bioaffinity Technologies Inc

BIAF Key Statistics

How BIAF Compares to Peers

Bioaffinity Technologies Inc Company Information

Upcoming Events for BIAF